ABSTRACT
Anemia was linked to poor maternal outcomes because of postpartum hemorrhage, antenatal sepsis, and postnatal sepsis. The main factors affecting postpartum anemia include prenatal iron-deficiency anemia and hemorrhage or blood loss. Iron-deficiency women are also at a higher risk of perinatal infections, preeclampsia, and bleeding. Iron-deficiency anemia is also linked to low fetal birthweight and premature delivery. A retrospective cohort study conducted in the United States found that the prevalence of postpartum anemia was 27%. Iron supplementation is necessary for treating anemia during pregnancy and during the postpartum period. Nutraceutical oral iron therapy can be ingested in the form of pills, capsules, and extended-release tablets. Studies investigating the benefits of parenteral iron therapy over the gold standard oral treatment are continuously being carried out, bringing us closer to the best treatment option for patients with postpartum anemia. Folic acid is used as an adjunct with other iron treatments to help increase iron and folate levels in the body.
